Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium

被引：10

作者：

Piccini, Jonathan P. ^{[1
,2
]}

Clark, Richard L. ^{[3
]}

Kowey, Peter R. ^{[4
,5
]}

Mittal, Suneet ^{[6
]}

Dunnmon, Preston ^{[7
]}

Stockbridge, Norman ^{[7
]}

Reiffel, James A. ^{[8
]}

Turakhia, Mintu P. ^{[9
,10
]}

Ziegler, Paul D. ^{[3
]}

Kleiman, Robert B. ^{[11
]}

Ismat, Fraz ^{[12
]}

Sager, Philip ^{[13
]}

机构：

[1] Duke Univ, Med Ctr, Durham, NC 27708 USA

[2] Duke Clin Res Inst, Durham, NC 27705 USA

[3] Mechron Diagnost & Monitoring Res, Mounds View, MN USA

[4] Lankenau Heart Inst, Philadelphia, PA USA

[5] Jefferson Med Coll, Philadelphia, PA USA

[6] Valley Hlth Syst, Ridgewood, NJ USA

[7] US FDA, Div Cardiovasc & Renal Prod, Rockville, MD 20857 USA

[8] Columbia Univ, Div Cardiol, Med Ctr, New York, NY USA

[9] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA

[10] Stanford Univ, Palo Alto, CA 94304 USA

[11] eRes Technol Inc ERT, Philadelphia, PA USA

[12] Bristol Myers Squibb, Princeton, NJ USA

[13] Stanford Univ, Stanford, CA 94305 USA

来源：

AMERICAN HEART JOURNAL | 2017年 / 187卷

关键词：

ATRIAL-FIBRILLATION; PROARRHYTHMIC RISK; HEPATITIS-C; SOFOSBUVIR; ARRHYTHMIAS; AMIODARONE; DEVICES; FOCUS;

D O I：

10.1016/j.ahj.2017.01.012

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This white paper, prepared by members of the Cardiac Safety Research Consortium (CSRC), discusses important issues regarding scientific and clinical aspects of long-term electrocardiographic safety monitoring during clinical drug development. To promote multistakeholder discussion of this topic, a Cardiac Safety Research Consortium sponsored Think Tank was held on 2 December 2015 at the American College of Cardiology's Heart House in Washington, DC. The goal of the Think Tank was to explore how and under what circumstances new and evolving ambulatory monitoring technologies could be used to improve and streamline drug development. This paper provides a detailed summary of discussions at the Think Tank: it does not represent regulatory guidance.

引用

页码：156 / 169

页数：14

共 50 条

[1] Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium
Sager, Philip T.
Gintant, Gary
Turner, J. Rick
Pettit, Syril
Stockbridge, Norman
AMERICAN HEART JOURNAL, 2014, 167 (03) : 292 - 300
[2] Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium
Sager, Philip T.
Seltzer, Jonathan
Turner, J. Rick
Anderson, Jeffrey L.
Hiatt, William R.
Kowey, Peter
Prochaska, Judith J.
Stockbridge, Norman
White, William B.
AMERICAN HEART JOURNAL, 2015, 169 (04) : 486 - 495
[3] Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium
Sager, Philip
Heilbraun, Jeffrey
Turner, J. Rick
Gintant, Gary
Geiger, Mary J.
Kowey, Peter R.
Mansoor, George A.
Mendzelevski, Boaz
Michelson, Eric L.
Stockbridge, Norman
Weber, Michael A.
White, William B.
AMERICAN HEART JOURNAL, 2013, 165 (04) : 477 - 488
[4] Long-Term Safety from the Raltegravir Clinical Development Program
Teppler, Hedy
Brown, Deborah D.
Leavitt, Randi Y.
Sklar, Peter
Wan, Hong
Xu, Xia
Lievano, Fabio
Lehman, Heidi P.
Mast, T. Christopher
Nguyen, Bach-Yen T.
CURRENT HIV RESEARCH, 2011, 9 (01) : 40 - 53
[5] Enabling social listening for cardiac safety monitoring: Proceedings from a drug information association-cardiac safety research consortium cosponsored think tank
Seifert, Harry A.
Malik, Raleigh E.
Bhattacharya, Mondira
Campbell, Kevin R.
Okun, Sally
Pierce, Carrie
Terkowitz, Jeffrey
Turner, J. Rick
Krucoff, Mitchell W.
Powell, Gregory E.
AMERICAN HEART JOURNAL, 2017, 194 : 107 - 115
[6] Letter to the Editor regarding "Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium"
Blankfield, Robert P.
AMERICAN HEART JOURNAL, 2013, 166 (03) : E9 - E9
[7] SAFETY OF LONG-TERM VIDEO EEG MONITORING
Noe, Katherine
Drazkowski, J.
EPILEPSIA, 2008, 49 : 54 - 54
[8] Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock
Samsky, Marc
Krucoff, Mitchell
Althouse, Andrew D.
Abraham, William T.
Adamson, Philip
Aguel, Fernando
Bilazarian, Seth
Dangas, George D.
Gilchrist, Ian C.
Henry, Timothy D.
Hochman, Judith S.
Kapur, Navin K.
Laschinger, John
Masters, Roy G.
Michelson, Eric
Morrow, David A.
Morrow, Valarie
Ohman, E. Magnus
Pina, Ileana
Proudfoot, Alastair G.
Rogers, Joseph
Sapirstein, John
Senatore, Fred
Stockbridge, Norman
Thiele, Holger
Truesdell, Alexander G.
Waksman, Ron
Rao, Sunil
AMERICAN HEART JOURNAL, 2020, 219 : 1 - 8
[9] LONG-TERM ASSESSMENT OF DRUG SAFETY AND EFFICACY
TURNER, P
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1984, 77 (02) : 93 - 94
[10] Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report Forms
Sabol, Mary Elizabeth
Finkle, John
Krucoff, Mitch
Stockbridge, Norman
Parkhill, Nancy
Shinagawa, Kaori
Mahaffey, Kenneth
Tcheng, James
Lenihan, Daniel
Melloni, Chiara
Todaro, Thomas
Michelson, Eric
Munley, Jiefen
Zander, Judith
Oh, Richard
THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (04) : 511 - 513

← 1 2 3 4 5 →